Search Results 21-30 of 17514 for CLL
-
This phase II trial studies how well pirtobrutinib and venetoclax work in treating patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
-
The laboratory research of Neil E. Kay, M.D., is focused on B-chronic lymphocytic leukemia (CLL). This most common and still incurable leukemia is not fully ...
-
A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls · Overview.
-
... chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or Non-Hodgkin's Lymphomas for which either the standard treatment has failed, is no ...
-
Mayo Clinic doctors and scientists are actively studying new ways of treating chronic lymphocytic leukemia. Blood cell and bone marrow cancer research is ...
-
... CLL /SLL therapies/regimens. This study also evaluates association of treatment patterns with patient characteristics, healthcare resource utilization and ...
-
Mayo Clinic doctors and scientists are actively studying new ways of treating chronic lymphocytic leukemia. Blood cell and bone marrow cancer research is ...
-
About this study. The purpose of this study is to investigate the efficacy and safety of lisaftoclax in combination with BTK inhibitors in CLL/SLL patients ...
-
Mayo Clinic doctors and scientists are actively studying new ways of treating chronic lymphocytic leukemia. Blood cell and bone marrow cancer research is ...
-
Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...